Filters

Mario Raviglione, Ben Marais, Katherine Floyd, Knut Lönnroth, Haileyesus Getahun, Giovanni B Migliori, Anthony D Harries, Paul Nunn, Christian Lienhardt, Steve Graham, Jeremiah Chakaya, Karin Weyer, Stewart Cole, Stefan H E Kaufmann, Alimuddin Zumla

Lancet (London, England) 2012;379(9829):1902-13

Full Text

Abstract

Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.

Jean-Louis Ruelle, Pascal Mettens, Erik Jongert, Marie-Cécile Mortier

BMC immunology 2016;16():63

Free Full Text

Abstract

ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis.

Fatema A Shaban, Abu S Mustafa

Tuberculosis (Edinburgh, Scotland) 2006;86(2):115-24

Full Text

Abstract

Analysis of predicted CD8+ T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis.

Jiuling Wang, Hongmei Zhang, Honghai Wang

Molecular biology reports 2010;37(4):1793-9

Full Text

Abstract

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Jes Dietrich, T Mark Doherty

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2009;117(5-6):440-57

Full Text

Abstract

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.

Helen A Fletcher, Helen McShane, Anna Checkley, Willem Hanekom, Hassan Mahomed, Greg Hussey, Rachel Tanner, Rod Chalk, Tony Hawkridge, Michelle Tameris, Tom Scriba, Clare R Sander, Ansar A Pathan, Ellen Miller, Kristina Kakalacheva

BMC infectious diseases 2015;14():660

Free Full Text

Abstract

Results: 1 – 15 / 17

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tuberculosis Vaccines""[mesh_terms]

TB vaccine strategies--what is needed to solve a complex problem?

The capsule: a cell structure with key implications in pathogenesis.

Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.

Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?

In silico design of Mycobacterium tuberculosis epitope ensemble vaccines.

In silico framework for designing and validating a multi-stage subunit vaccine against Tuberculosis using reverse vaccinology approach.

The effect of the host's iron status on tuberculosis.

Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.

A 2-Dose AERAS-402 Regimen Boosts CD8 Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients.

Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.

ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis.

Analysis of predicted CD8+ T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis.

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.

Results for
""Tuberculosis Vaccines""[mesh_terms]